Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-3.35 Insider Own29.67% Shs Outstand42.95M Perf Week12.20%
Market Cap59.56M Forward P/E- EPS next Y-2.50 Insider Trans15.88% Shs Float30.36M Perf Month3.76%
Income-143.04M PEG- EPS next Q-0.67 Inst Own56.47% Short Float / Ratio9.98% / 8.12 Perf Quarter-18.82%
Sales0.00M P/S- EPS this Y-93.03% Inst Trans10.33% Short Interest3.03M Perf Half Y-74.21%
Book/sh4.52 P/B0.31 EPS next Y23.90% ROA-48.69% Target Price15.67 Perf Year-92.97%
Cash/sh4.25 P/C0.33 EPS next 5Y29.10% ROE-55.84% 52W Range1.10 - 19.98 Perf YTD-84.56%
Dividend- P/FCF- EPS past 5Y50.81% ROI-67.05% 52W High-93.09% Beta1.78
Dividend %- Quick Ratio9.40 Sales past 5Y362.10% Gross Margin79.96% 52W Low25.45% ATR0.11
Employees132 Current Ratio9.40 Sales Q/Q- Oper. Margin0.00% RSI (14)59.30 Volatility10.34% 8.19%
OptionableYes Debt/Eq0.11 EPS Q/Q-119.73% Profit Margin- Rel Volume0.81 Prev Close1.37
ShortableYes LT Debt/Eq0.10 EarningsNov 08 AMC Payout- Avg Volume373.44K Price1.38
Recom1.80 SMA2014.95% SMA505.93% SMA200-62.39% Volume302,863 Change0.73%
Date Action Analyst Rating Change Price Target Change
Jun-27-23Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-27-23Downgrade Guggenheim Buy → Neutral
Jun-01-23Downgrade JP Morgan Overweight → Neutral $20 → $6
Sep-21-22Initiated JP Morgan Overweight $23
Mar-31-22Initiated SMBC Nikko Outperform $28
Mar-08-22Initiated Truist Buy $30
Mar-04-22Initiated Jefferies Buy $27
May-18-21Initiated BTIG Research Buy $34
Apr-23-21Initiated H.C. Wainwright Buy $27
Apr-14-21Initiated Canaccord Genuity Buy $28
Nov-08-23 04:10PM
Nov-07-23 07:00AM
Nov-02-23 09:00AM
Oct-31-23 06:25PM
Oct-04-23 12:00PM
05:24PM Loading…
Sep-29-23 05:24PM
Sep-27-23 09:00AM
Aug-31-23 04:35PM
Aug-12-23 08:16AM
Aug-09-23 04:15PM
Aug-02-23 04:00PM
Jul-31-23 04:50PM
Jul-11-23 08:30AM
Jun-30-23 04:51PM
Jun-26-23 04:00PM
07:00AM Loading…
Jun-01-23 07:00AM
May-31-23 04:53PM
May-18-23 06:00AM
May-09-23 04:30PM
Apr-28-23 05:13PM
Apr-26-23 08:01PM
Apr-17-23 06:58AM
Apr-13-23 07:00AM
Apr-04-23 02:47PM
Mar-31-23 04:31PM
Mar-15-23 04:01PM
Mar-09-23 07:00AM
Mar-05-23 07:09AM
05:31PM Loading…
Feb-28-23 05:31PM
Feb-01-23 07:00AM
Jan-31-23 08:40PM
Dec-30-22 04:43PM
Dec-20-22 08:23AM
Dec-10-22 10:00AM
Dec-02-22 07:00AM
Nov-30-22 08:08PM
Nov-29-22 07:00AM
Nov-11-22 05:24AM
Nov-08-22 04:10PM
Nov-07-22 08:00AM
Nov-03-22 09:00AM
Nov-01-22 07:00AM
Oct-31-22 06:58PM
Oct-23-22 08:39AM
Oct-05-22 08:00AM
Sep-30-22 06:59PM
Sep-26-22 06:26AM
Sep-07-22 04:10PM
Aug-31-22 05:30PM
Aug-16-22 06:16AM
Aug-10-22 07:00AM
Aug-01-22 04:10PM
Jul-29-22 06:05PM
Jul-01-22 04:10PM
Jun-21-22 04:10PM
Jun-06-22 07:00AM
Jun-03-22 04:10PM
May-26-22 05:00PM
May-18-22 04:00PM
May-15-22 08:21AM
May-12-22 04:10PM
May-05-22 07:00AM
May-04-22 04:10PM
Apr-27-22 10:00AM
Apr-19-22 07:00AM
Apr-07-22 04:10PM
Apr-01-22 04:10PM
Mar-22-22 12:47PM
Mar-15-22 04:00PM
Mar-04-22 04:00PM
Feb-02-22 07:00AM
Dec-10-21 04:01PM
Dec-09-21 05:49PM
Dec-08-21 01:13AM
Dec-07-21 04:16PM
Dec-06-21 07:00AM
Nov-29-21 07:00AM
Nov-20-21 06:00AM
Nov-18-21 07:00AM
Nov-12-21 07:00AM
Nov-10-21 04:01PM
Nov-08-21 07:00AM
Nov-04-21 09:00AM
Oct-26-21 03:00AM
Oct-12-21 04:10PM
Oct-04-21 07:00AM
Sep-13-21 08:00AM
Sep-02-21 04:53PM
Aug-12-21 04:01PM
Aug-02-21 07:00AM
Jul-30-21 10:35AM
Jul-15-21 07:00AM
Jun-28-21 07:00AM
May-18-21 04:10PM
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of "off-the-shelf" gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schor ChenPresident & CEOOct 02Buy1.335,5007,34043,469Oct 02 08:16 PM
Schor ChenPresident & CEOSep 29Sale1.365,5007,481176,969Oct 02 08:16 PM
Schor ChenPresident & CEOSep 28Buy1.425,5007,810182,469Oct 02 08:16 PM
Schor ChenPresident & CEOSep 28Sale1.425,5007,81037,969Oct 02 08:16 PM
DUBIN STEVEDirectorJun 30Buy2.405,00012,00010,900Jun 30 04:08 PM
GORDON CARL LDirectorJun 27Buy2.09875,0001,828,7505,685,259Jun 29 04:51 PM
ORBIMED ADVISORS LLCDirectorJun 27Buy2.09875,0001,828,7505,685,259Jun 29 04:46 PM
Healey DonChief Technology OfficerFeb 15Sale7.574,53334,32766,568Feb 17 08:22 PM
Healey DonChief Technology OfficerFeb 10Sale7.9810,46783,47671,101Feb 14 04:50 PM